Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. A study in experimental animals and in clinical material.
D000614:Aminocaproates / Q000009:adverse effects*; D000818:Animals; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006614:Hindlimb / Q000293:injuries; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D010690:Phlebography; D011468:Prostatectomy; D011817:Rabbits; D013924:Thrombophlebitis / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control; D013927:Thrombosis / Q000139:chemically induced* / Q000453:epidemiology
D000614:Aminocaproates; D006493:Heparin